Drug General Information
Drug ID
D04QZD
Former ID
DNC000619
Drug Name
Eslicarbazepine
Synonyms
Aptiom; BIA 2-093; ESL; Exalief; SEP-0002093; SEP-2093; Stedesa; Zebinix
Drug Type
Small molecular drug
Indication Seizures [ICD9: 345.9, 780.3; ICD10:G40, P90, R56] Approved [532651], [542371]
Therapeutic Class
Neurology Agents
Structure
Download
2D MOL

3D MOL

Formula
C15H14N2O2
InChI
InChI=1S/C15H14N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8,14,18H,9H2,(H2,16,19)/t14-/m0/s1
InChIKey
BMPDWHIDQYTSHX-AWEZNQCLSA-N
CAS Number
CAS 236395-14-5
PubChem Compound ID
PubChem Substance ID
SuperDrug ATC ID
N03AF04
Target and Pathway
Target(s) Sodium channel Target Info Blocker [536934]
KEGG Pathway Dopaminergic synapse
Reactome Interaction between L1 and Ankyrins
References
Ref 5326512013 FDA drug approvals. Nat Rev Drug Discov. 2014 Feb;13(2):85-9.
Ref 542371(http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7350).
Ref 536934Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX). Epilepsy Res. 2009 Jan;83(1):1-43. Epub 2008 Nov 12.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.